The earnings call highlighted significant revenue growth, particularly in the OviTex and LIQUIFIX portfolios, as well as successful expansion in the European market. However, the company still faces challenges with its net loss and slight increase in sales and marketing expenses. Overall, the positive achievements outweighed the challenges.

Company Guidance -

Q3 2025

During TELA Bio's Q2 2025 earnings call, the company outlined significant metrics and strategic guidance. TELA Bio reported a revenue of $20.2 million for the quarter, marking a 26% year-over-year increase. The OviTex reinforced tissue matrix portfolio saw a 12% revenue growth, while the OviTex PRS portfolio experienced a 53% rise in sales. Notably, OviTex unit sales grew by 17%, and OviTex PRS unit sales increased by 40%. LIQUIFIX revenue grew by 121% year-over-year, and OviTex IHR showed a 322% revenue increase compared to Q2 2024. The company reiterated its full-year 2025 guidance, projecting revenue between $85 million and $88 million, representing a 23% to 27% growth over 2024. Gross margin improved to 69.8%, and net loss decreased from $12.6 million in Q2 2024 to $9.9 million. TELA Bio ended the quarter with $35 million in cash and cash equivalents. The company emphasized a shift towards a patient-centric sales strategy and highlighted new leadership and strategic hires to drive future growth.

Record Revenue Achievement

Q2 2025 set a new high watermark for TELA Bio as the first quarter to exceed $20 million in revenue.

OviTex and OviTex PRS Sales Growth

OviTex reinforced tissue matrix portfolio scaled with over 73,000 units sold in the U.S. and Europe, and OviTex PRS portfolio reached more than 16,000 units sold in the U.S.

LIQUIFIX Revenue Growth

Year-over-year LIQUIFIX revenue grew by 121% in Q2 2025.

European Expansion Success

European sales grew 25% over Q2 last year, driven by 29% unit growth.

Gross Margin Improvement

Gross margin was 69.8% for Q2 2025 compared to 68.8% in the prior year period.

TELA Bio (TELA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TELA Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	-0.19 / -	-0.42	―	―	―
Aug 11, 2025	2025 (Q2)	-0.18 / -0.22	-0.51	56.86% (+0.29)	―
May 08, 2025	2025 (Q1)	-0.20 / -0.25	-0.23	-8.70% (-0.02)	―
Mar 20, 2025	2024 (Q4)	-0.21 / -0.23	-0.53	56.60% (+0.30)	―
Nov 07, 2024	2024 (Q3)	-0.41 / -0.42	-0.45	6.67% (+0.03)	―
Aug 12, 2024	2024 (Q2)	-0.46 / -0.51	-0.46	-10.87% (-0.05)	―
May 09, 2024	2024 (Q1)	-0.49 / -0.23	-0.63	63.49% (+0.40)	―
Mar 21, 2024	2023 (Q4)	-0.45 / -0.53	-0.52	-1.92% (-0.01)	―
Nov 09, 2023	2023 (Q3)	-0.48 / -0.45	-0.64	29.69% (+0.19)	―
Aug 09, 2023	2023 (Q2)	-0.52 / -0.46	-0.88	47.73% (+0.42)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TELA Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 11, 2025	$1.86	$1.60	-13.98%
May 08, 2025	$0.99	$1.08	+9.09%
Mar 20, 2025	$2.34	$1.47	-37.18%
Nov 07, 2024	$2.99	$3.08	+3.01%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does TELA Bio (TELA) report earnings?

TELA Bio (TELA) is schdueled to report earning on Nov 05, 2025, Before Open (Confirmed).

What is TELA Bio (TELA) earnings time?

TELA Bio (TELA) earnings time is at Nov 05, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TELA EPS forecast?

TELA EPS forecast for the fiscal quarter 2025 (Q3) is -0.19.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing